Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Global - Population 60 Years or Above (Billion), 2015, 2030 & 2050
Figure 5-1: Global - Hepatocellular Carcinoma Drug Market, (Billion US$), 2016 & 2022
Figure 6-1: Global - Hepatocellular Carcinoma Companies Drug Pipeline, by Clinical Phase, (%) 2016
Figure 6-2: Global - Hepatocellular Carcinoma Research Organization Drug Pipeline by Clinical Phase, (%), 2016
Figure 7-1: Global - Hepatocellular Carcinoma Drug Market by Geography (%), 2016
Figure 7-2: North America - Global Hepatocellular Carcinoma Market (Billion US$), 2016 & 2022
Figure 7-3: Europe - Global Hepatocellular Carcinoma Market (Billion US$), 2016 & 2022
Figure 7-4: Asia Pacific - Hepatocellular Carcinoma Drug Market (Billion US$), 2016 & 2022
Figure 8-1: Pfizer Inc. - Revenue by Business Segments (%), 2016
Figure 8-2: Pfizer Inc. - Revenue by Geography (%), 2016
Figure 8-3: Eli Lilly and Company - Revenue by Business Segments (%), 2016
Figure 8-4: Eli Lilly and Company - Revenue by Geography (%), 2016
Figure 8-5: Bayer AG - Revenue by Business Segments (%), 2016
Figure 8-6: Bayer AG - Revenue by Geography (%), 2016
Figure 8-7: Teva Pharmaceutical Industries Ltd. - Revenue by Business Segments (%), 2016
Figure 8-8: Teva Pharmaceutical industries Ltd. - Revenue by Geography (%), 2016
Figure 8-9: Bristol-Mayers Squibb - Revenue by Geography (%), 2016

List of Tables:

Table 5-1: Global - Drugs with Orphan Drugs Status for Hepatocellular Carcinoma
Table 6-1: Global - Hepatocellular Carcinoma Drug in Pipeline by Companies
Table 6-2: Global - Hepatocellular Carcinoma Drug in Pipeline by Research Organization
Table 8-1: Pfizer Inc. - Financials (Million US$), 2014-2016
Table 8-2: Eli Lilly and Company - Financials (Billion US$), 2014-2016
Table 8-3: Alnylam Pharmaceuticals, Inc. - Financials (Billion US$), 2014-2016
Table 8-4: Exelixis, Inc. - Financials (Billion US$), 2014-2016
Table 8-5: Arqule - Financials (Billion US$), 2014-2016
Table 8-6: Bayer AG - Financials (Million US$), 2014-2016
Table 8-7: Teva Pharmaceutical Industries ltd. - Financials (Million US$), 2014-2016
Table 8-8: Bristol-Mayers Squibb - Financials (Billion US$), 2014-2016